Tomasz Burzykowski
358 works · 12,035 citations · h-index 52
Top works
- Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis
- The validation of surrogate endpoints in meta-analyses of randomized experiments
- Progression-Free Survival Is a Surrogate for Survival in Advanced Colorectal Cancer
- Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer
- Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
- Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
- Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
- Surrogate threshold effect: an alternative measure for meta‐analytic surrogate endpoint validation
- Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer
- Statistical challenges in the evaluation of surrogate endpoints in randomized trials
- Is Prostate-Specific Antigen a Valid Surrogate End Point for Survival in Hormonally Treated Patients With Metastatic Prostate Cancer? Joint Research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca Pharmaceuticals
- Radiographic Progression-Free Survival As a Response Biomarker in Metastatic Castration-Resistant Prostate Cancer: COU-AA-302 Results
- High prevalence of foot diseases in Europe: results of the Achilles Project
- Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas?
- Linear Mixed-Effects Models Using R
- The Validation of Surrogate End Points by using Data from Randomized Clinical Trials: A Case-Study in Advanced Colorectal Cancer
- Individual- and trial-level surrogacy in colorectal cancer
- Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis
- Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer
- Reintroduction of Oxaliplatin Is Associated With Improved Survival in Advanced Colorectal Cancer